Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy

Table 1 Characteristics of 58 patients with non-small cell lung cancer enrolled in the study

Characteristic	Number	ROMs level (U.CARR)	p
Gender
Male	43	437 ± 144
Female	15	356 ± 81	0.134
Histology
Adenocarcinoma	50	395 ± 107
Squamous cell carcinoma	8	549 ± 209	0.032*
Performance status
0	41	419 ± 149
1	17	410 ± 96	0.139
Clinical stage
IIIB	21	405 ± 110
IV	37	423 ± 148	0.407
Smoking history
Current/former smoker	45	439 ± 143
Non-smoker	13	340 ± 55	0.040*

ROMs levels are expressed as mean ± SD. Mean values were compared by unpaired-t test. *: p < 0.05. ROMs, reactive oxygen metabolites; U.CARR, Carratelli Units.

ISSN: 2049-6958